Tigermed, a global leader in clinical research solutions, has proudly completed the acquisition of Micron, Inc.—a highly respected Japanese Contract Research Organization (CRO) known for its pioneering work in medical imaging and clinical trial support. This acquisition marks a significant milestone for both companies and strengthens Tigermed’s foothold in Japan and the broader Asia-Pacific region.

Founded in 2005 and headquartered in Tokyo, Micron has spent nearly two decades shaping the clinical imaging landscape. With a team of over 160 professionals, including the largest group of imaging experts in Asia, Micron has supported more than 250 clients and contributed to the successful approval of over 40 therapeutic products. It was the first CRO in Japan to specialize in imaging and has built a strong reputation through its early adoption of imaging biomarkers, AI-powered imaging tools, and deep client trust across the medical field.

Top IntentTech News: Emergence AI Launches CRAFT for Smarter Data Automation

As part of the integration, Micron will become a key part of Tigermed Japan, helping to elevate Tigermed’s service offerings in clinical imaging across the region. This move brings together Micron’s rich expertise and strong local presence with Tigermed’s expansive global infrastructure—creating a platform capable of delivering even more comprehensive, tech-forward solutions for pharmaceutical and medical device development.

Mr. Hiroaki Suzuki, President and Co-founder of Micron, spoke of the future with excitement: “Coming aboard at Tigermed is an amazing opportunity. We’ve always had a mission to promote human health by utilizing advanced imaging technology. Now, with the reach and resources of Tigermed, we can take that mission even further, creating new possibilities and amplifying our influence across the globe.”

Top IntentTech News: IPValue and Longitude License Semiconductor Patents to Samsung

Tigermed’s Co-President, Mr. Michael Wen, echoed the sentiment: “Micron brings unique technological strengths and a stellar track record that aligns perfectly with our vision. Their addition enhances our capabilities in medical imaging and strengthens our position in the Asia-Pacific market. Together, we’re positioned to make an even greater contribution to the progress of global clinical research.”

With this acquisition, Tigermed continues its growth as a truly global CRO, deepening its commitment to innovation, quality, and collaboration in the pursuit of better health outcomes around the world.

Top IntentTech News: Ireland Rail Upgrade to Boost Connectivity and Sustainability

To participate in our interviews, please write to our IntentTech Media Room at sudipto@intentamplify.com